Abstract
Abstract
Purpose
Translocator protein 18-kDa (TSPO) imaging with positron emission tomography (PET) is widely used in research studies of brain diseases that have a neuro-immune component. Quantification of TSPO PET images, however, is associated with several challenges, such as the lack of a reference region, a genetic polymorphism affecting the affinity of the ligand for TSPO, and a strong TSPO signal in the endothelium of the brain vessels. These challenges have created an ongoing debate in the field about which type of quantification is most useful and whether there is an appropriate simplified model.
Methods
This review focuses on the quantification of TSPO radioligands in the human brain. The various methods of quantification are summarized, including the gold standard of compartmental modeling with metabolite-corrected input function as well as various alternative models and non-invasive approaches. Their advantages and drawbacks are critically assessed.
Results and conclusions
Researchers employing quantification methods for TSPO should understand the advantages and limitations associated with each method. Suggestions are given to help researchers choose between these viable alternative methods.
Funder
National Institute of Mental Health
Siemens Healthineers
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference77 articles.
1. DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. Journal of Neurochemistry. John Wiley & Sons, Ltd. 2016;139 Suppl 2:136–53.
2. Nutma E, Ceyzériat K, Amor S, Tsartsalis S, Millet P, Owen DRJ, et al. Cellular sources of TSPO expression in healthy and diseased brain. Eur. J. Nucl. Med. Mol. Imaging. Springer Berlin Heidelberg. 2021;194:44–18.
3. Junck L, Olson JM, Ciliax BJ, Koeppe RA, Watkins GL, Jewett DM, et al. PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol. 1989;26:752–8.
4. Banati RB, Myers R, Kreutzberg GW. PK (“peripheral benzodiazepine”) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H] PK 11195 binding to activated microglia. J Neurocytol. 1997;26:77–82.
5. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer FE, Heppner F, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis. Brain. 2000;123:2321–37.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献